Drug interactions involving antifungal drugs: Time course and clinical significance

被引：6
作者：
Bartell A. [1 ]
Phatak A. [1 ]
Horn K. [1 ]
Postelnick M. [1 ]
机构：
[1] Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL 60611
来源：
Current Fungal Infection Reports | 2010年 / 4卷 / 2期
关键词：
Azoles; Drug interactions; Echinocandins; Polyenes;
D O I：
10.1007/s12281-010-0014-x
中图分类号：
学科分类号：
摘要：
The antifungal armamentarium has expanded greatly over the past two decades. This expansion, along with the pharmacologically complex therapeutic regimens used in treating many patients with systemic fungal disease, enhances the risk of clinically significant drug-drug interactions. This review examines the drug-drug interaction potential of antifungal agents by pharmacologic class and attempts to provide perspective on the time course and clinical significance of these events. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：103 / 110
页数：7
相关论文
共 50 条
[1]  
Valeriote F., Medoff G., Tolen S., Dieckman J., Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice, Journal of the National Cancer Institute, 73, 2, pp. 475-482, (1984)
[2]  
Valeriote F., Medoff G., Dieckman J., Potentiation of cytotoxicity of anticancer agents by several different polyene antibiotics, Journal of the National Cancer Institute, 72, 2, pp. 435-439, (1984)
[3]  
Ozols R.F., Hogan W.M., Grotzinger K.R., Effects of amphotericin B on Adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia, Cancer Research, 43, 3, pp. 959-964, (1983)
[4]  
Valeriote F., Medoff G., Dieckman J., Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B, Cancer Research, 39, 6 I, pp. 2041-2045, (1979)
[5]  
Saad A.H., DePestel D.D., Carver P.L., Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants, Pharmacotherapy, 26, 12 I, pp. 1730-1744, (2006)
[6]  
Sugar A.M., Saunders C., Idelson B.A., Bernard D.B., Interaction of fluconazole and cyclosporine, Ann Intern Med, 110, (1989)
[7]  
Diflucan [Prescribing Information], (2008)
[8]  
Blum R.A., Wilton J.H., Hilligoss D.M., Et al., Effect of fluconazole on the disposition of phenytoin, Clin Pharmacol Ther, 49, pp. 420-425, (1991)
[9]  
Tarumi Y., Perira J., Watanabe S., Methadone and fluconazole: Respiratory depression by drug interaction, J Pain Symptom Manage, 23, pp. 286-298, (2002)
[10]  
Cobb M.N., Desai J., Brown Jr. L.S., Zannikos P.N., Rainey P.M., The effect of fluconazole on the clinical pharmacokinetics of methadone, Clinical Pharmacology and Therapeutics, 63, 6, pp. 655-662, (1998)
12345